Post-Traumatic Stress Disorder Clinical Trial
Official title:
Comparative Study of the Efficacy of a Cognitive-Behavioral Therapy for Post-Traumatic Stress Disorder With or Without D-Cycloserine
The purpose of this study is to investigate if the effectiveness of cognitive-behavioral therapy for post-traumatic stress disorder can be increased by combining it with D-cycloserine (TCC/D-cycloserine) by comparing with a placebo (TCC/placebo).
Post-traumatic stress disorder (PTSD) is one of the most frequent anxiety disorder in the
general population (Kessler and al., 2005). Currently, the treatment of choice for PTSD is
cognitive-behavioral therapy (CBT; Foa, Davidson and Frances, 1999). Based on remission
rates after treatment, successful outcomes of CBT for PTSD vary between 46 and 54 % when
dropouts are considered, and between 56 and 70% among those who completed their therapy
(Bradley and al., 2005). Thus, there is room for improvement.
Recently, the results of two published studies on the treatment of phobia of heights
(Ressler and al., 2004) and social phobia (Hofman, 2006) indicated that the efficacy of CBT
was increased by adding D-cycloserine. The superior efficacy of CBT/D-cycloserine over
CBT/Placebo in the treatment of anxiety disorders can result from a greater release of
glutamate, a substance facilitating the extinction of fear (Davis, Myers, Ressler and
Rothbaum, 2005; Richardson, Ledgerwood an Cranney, 2004). However, to our knowledge, no
study has yet compared CBT/D-cycloserine to CBT/Placebo in the treatment of PTSD. The main
hypothesis of the current study is that the efficacy of CBT for PTSD will be increased when
combined with D-cycloserine compared to a placebo.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04317820 -
Deep Brain Reorienting in Post-traumatic Stress Disorder
|
N/A | |
| Completed |
NCT05112003 -
Translingual Neurostimulation for the Virtual Treatment of Post-Traumatic Stress Disorder: A Feasibility Pilot
|
N/A | |
| Recruiting |
NCT04518267 -
Anger and Psychotrauma: Data From Military and Civilians
|
||
| Completed |
NCT02502604 -
Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder
|
N/A | |
| Completed |
NCT02256566 -
Cognitive Training for Mood and Anxiety Disorders
|
N/A | |
| Terminated |
NCT02234687 -
A mGlu2/3 Agonist in the Treatment of PTSD
|
Phase 1 | |
| Terminated |
NCT02520726 -
PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims
|
Phase 4 | |
| Completed |
NCT01738308 -
The Effects of Healing Touch on Post Operative Pediatric Patients
|
N/A | |
| Completed |
NCT02213900 -
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
|
Phase 4 | |
| Completed |
NCT01437891 -
Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF)
|
N/A | |
| Completed |
NCT01517711 -
Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD)
|
Phase 4 | |
| Completed |
NCT01998100 -
Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
|
Phase 3 | |
| Completed |
NCT01199107 -
Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)
|
Phase 3 | |
| Completed |
NCT01231711 -
Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based Intervention
|
Phase 1 | |
| Completed |
NCT00348036 -
Group Intervention for Interpersonal Trauma
|
N/A | |
| Completed |
NCT00838006 -
Psychophysiologic Predictors of Post-deployment Mental Health Outcomes
|
N/A | |
| Completed |
NCT00680524 -
Telephone-based Care for OEF/OIF Veterans With PTSD
|
N/A | |
| Completed |
NCT00525226 -
Evaluating the Effects of Stress in Pregnancy
|
N/A | |
| Completed |
NCT00183690 -
Prolonged Exposure Therapy Versus Active Psychotherapy in Treating Post-Traumatic Stress Disorder in Adolescents
|
Phase 1 | |
| Completed |
NCT00158262 -
Effect of Propranolol on Preventing Posttraumatic Stress Disorder
|
Phase 4 |